Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • Italia
    • Utenti registrati
    • 0039 0424-472449 Richiedi informazioni
    • 0039 0424-472449 Richiedi informazioni
    ItalyItaly
      • Part of brands: |
        • Guida
          • Prevenzione di malattie ereditarie
          • Gravidanza serena
        • I nostri servizi
          • Per gli specialisti della salute
          • Per i pazienti
        • Diagnostica
        • Chi Siamo
          • Igenomix Research
          • Chi siamo
        • Webinars
        Genomics Precision Diagnostic > Rare Disease Precision Panel > Cornelia de Lange Syndrome  Precision Panel

        Cornelia de Lange Syndrome Precision Panel

        Cornelia de Lange Syndrome (CdLS) is archetypical genetic syndrome characterized by intellectual disability, distinct facial features, upper limb anomalies, pernatal and postnatal growth retardation among other signs and symptoms. 
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Cornelia de Lange Syndrome (CdLS) is archetypical genetic syndrome characterized by intellectual disability, distinct facial features, upper limb anomalies, pernatal and postnatal growth retardation among other signs and symptoms. It is caused by mutations in genes that have a structural or regulatory function in the cohesion complex. Cohesin is a protein that plays a pivotal role in chromatid cohesion, gene expression and DNA repair. It is transmitted in an autosomal dominant and X-linked pattern.  
        • The Igenomix Cornelia de Lange Syndrome Precision Panel can serve as a directed and accurate diagnostic tool ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes. 

           

        Indication

        • The Igenomix Cornelia de Lange Syndrome Precision Panel is indicated in those cases where there is a clinical suspicion or diagnosis with or without the following manifestations:  
          • Intrauterine growth retardation 
          • Prematurity 
          • Facial features: arched eyebrows, short nose with depressed bridge, long philtrum, thin lips etc 
          • Low-pitched, weak cry in infancy 
          • Increased muscle tone
          • Respiratory and feeding difficulties 
          • Developmental delay 
          • Intellectual disability 
          • Seizures 

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular diagnosis for an accurate clinical diagnosis and improve prognosis. 
        • Early initiation of treatment with a multidisciplinary team in the form nutritional rehabilitation, hearing and visual aids, surgical repair of congenital heart disease and urinary system abnormalities with pertinent consultations to specialists.  
        • Risk assessment and genetic counselling of asymptomatic family members to identify the individuals at risk. 
        • Improvement of delineation of genotype-phenotype correlation.  

        Genes & Diseases

        Methodology

        References

        See scientific referrals

        Kline, A. D., Moss, J. F., Selicorni, A., Bisgaard, A. M., Deardorff, M. A., Gillett, P. M., Ishman, S. L., Kerr, L. M., Levin, A. V., Mulder, P. A., Ramos, F. J., Wierzba, J., Ajmone, P. F., Axtell, D., Blagowidow, N., Cereda, A., Costantino, A., Cormier-Daire, V., FitzPatrick, D., Grados, M., … Hennekam, R. C. (2018). Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement. Nature reviews. Genetics, 19(10), 649–666. https://doi.org/10.1038/s41576-018-0031-0 

        Boyle, M. I., Jespersgaard, C., Brøndum-Nielsen, K., Bisgaard, A. M., & Tümer, Z. (2015). Cornelia de Lange syndrome. Clinical genetics, 88(1), 1–12. https://doi.org/10.1111/cge.12499 

        Sarogni, P., Pallotta, M. M., & Musio, A. (2020). Cornelia de Lange syndrome: from molecular diagnosis to therapeutic approach. Journal of medical genetics, 57(5), 289–295. https://doi.org/10.1136/jmedgenet-2019-106277 

        Huisman, S., Redeker, E., Maas, S., Mannens, M., & Hennekam, R. (2013). High rate of mosaicism in individuals with Cornelia de Lange syndrome. Journal Of Medical Genetics, 50(5), 339-344. doi: 10.1136/jmedgenet-2012-101477 

        Dowsett, L., Porras, A. R., Kruszka, P., Davis, B., Hu, T., Honey, E., Badoe, E., Thong, M. K., Leon, E., Girisha, K. M., Shukla, A., Nayak, S. S., Shotelersuk, V., Megarbane, A., Phadke, S., Sirisena, N. D., Dissanayake, V., Ferreira, C. R., Kisling, M. S., Tanpaiboon, P., … Krantz, I. D. (2019). Cornelia de Lange syndrome in diverse populations. American journal of medical genetics. Part A, 179(2), 150–158. https://doi.org/10.1002/ajmg.a.61033 

        descargar

        Detail description

        Download

        BROCHURE

        Download

        Request Information


        • reCAPTCHA demo: Simple page

        GUIDA

        Fertilità
        Prevenzione di malattie ereditarie
        Gravidanza serena

        I NOSTRI SERVIZI

        Soluzioni genetiche
        Informazioni sulla genetica

        PANORAMICA

        Informazioni su Igenomix
        Contatti
        Come inviare un campione
        Qualità
        Lavora con noi
        News and Press

           0039 0424-472449
        Contatti
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        Linguaggio

        [2019] © Igenomix Politica sulla privacyPolitica qualità Politica dei cookie       Soddisfazione       Manuale dell’utente

        Richiedi informazioni








        • reCAPTCHA demo: Simple page











        • Guida
          • Prevenzione di malattie ereditarie
          • Gravidanza serena
        • I nostri servizi
          • Per gli specialisti della salute
          • Per i pazienti
        • Diagnostica
        • Chi Siamo
          • Igenomix Research
          • Chi siamo
        • Webinars
        • Italia
        • Utenti registrati
        • Area pazienti
        • Area cliniche

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        Italy
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.